Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV.
Condition(s):Hepatitis C; Cirrhosis; Antiviral Drug Adverse ReactionLast Updated:December 19, 2018Unknown status
Hide Studies Not Open or Pending
Condition(s):Hepatitis C; Cirrhosis; Antiviral Drug Adverse ReactionLast Updated:December 19, 2018Unknown status
Condition(s):Hepatitis CLast Updated:July 24, 2017Unknown status
Condition(s):Chronic Hepatitis CLast Updated:March 10, 2020Recruiting
Condition(s):Antiviral DrugLast Updated:May 29, 2019Not yet recruiting
Condition(s):Antiviral Drug Adverse ReactionLast Updated:September 29, 2017Unknown status
Condition(s):Viral Hepatitis C; Therapy Adverse EffectLast Updated:June 25, 2018Completed
Condition(s):Facial PalsyLast Updated:September 16, 2020Completed
Condition(s):Hepatitis CLast Updated:February 18, 2021Completed
Condition(s):Chronic Hepatitis bLast Updated:February 12, 2018Unknown status
Condition(s):Vasculitis; Cryoglobulinemia; Hepatitis CLast Updated:September 29, 2016Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.